---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "kXlyAkDd+Qq/XLjV2I8JJVQAi6jXrpPlr/43vqkK7h2WLC6WgPA4U7LxINcQ5NEcyefmX3qHra4jm0dpgIFe+JAKUbm6FxiZzMzEfftCMZF4q4l1nW/Ensy2RckRCZC85+KS+fY06irSkAXLqZwU9yfkpCCqtSi4NVE1MAgWt9vSumWibAXp5kxO3cCScVM/ykYYUBqi41jM2f+u4tMek+66YImdV0PsaXpdpuogUdM0O2ZfCQrOOIwdROXoS+yYo00djzPz1akruJEDMOM2qRVcQP1L7kdoozlUevQChQ2+GC42+YH8O/pYpHT4fPHrsD06a6VHasyxjh+lBSJdhXxs39XhAB3bqpQwayprNUc=;orekxca4KxKEWhnq50/xfw=="
---

